European Economic and Social Committee 25 October 2023, Opinion of the European Economic and Social Committee on (a) the communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions — Reform of the pharmaceutical legislation and measures addressing antimicrobial resistance (COM(2023) 190 final), (b) the proposal for a Council Recommendation on stepping up EU actions to combat antimicrobial resistance in a One Health approach (COM(2023) 191 final — 2023/0125 (NLE)), (c) the proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC (COM(2023) 192 final — 2023/0132 (COD)) and (d) the proposal for a Regulation of the European Parliament and of the Council laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governi...
Also known as
European Union · · · Cited by 4 · 25-10-2023
Official Journal of the European Union EN Series C C/2024/879 6.2.2024 Opinion of the European Economic and Social Committee on (a) the communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions — Reform of the pharmaceutical legislation and measures addressing antimicrobial resistance (COM(2023) 190
Read the full text
This document is published by eur-lex.europa.eu.
Moonlit adds the citation network (4 references), article-level links and cross-references, which are available to search for free.
Sign in to Moonlit